Despite the NiPPeR study participants being generally healthy women delivering in high-resource settings with advanced medical care and widespread use of prophylactic oxytocin against PPH, it is remarkable that variations in plasma myo-inositol in pregnancy could still be associated with a discernible difference in PBL. The gene discussed is OXT; the disease is pulmonary arterial hypertension.